Financials data is unavailable for this security.
View more
Year on year Chemometec A/S 's revenues fell -8.22%from 444.40m to 407.87m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a -23.72% reduction in net income from 178.67m to 136.28m.
| Gross margin | 78.80% |
|---|---|
| Net profit margin | 33.41% |
| Operating margin | 41.43% |
| Return on assets | 20.42% |
|---|---|
| Return on equity | 24.82% |
| Return on investment | 24.40% |
More ▼
Cash flow in DKKView more
In 2024, cash reserves at Chemometec A/S fell by 20.43m. However, the company earned 129.00m from its operations for a Cash Flow Margin of 31.63%. In addition the company used 43.49m on investing activities and also paid 105.72m in financing cash flows.
| Cash flow per share | 8.85 |
|---|---|
| Price/Cash flow per share | 54.74 |
| Book value per share | 32.48 |
|---|---|
| Tangible book value per share | 27.05 |
More ▼
Balance sheet in DKKView more
| Current ratio | 4.97 |
|---|---|
| Quick ratio | 3.76 |
| Total debt/total equity | 0.0074 |
|---|---|
| Total debt/total capital | 0.0073 |
More ▼
Growth rates in DKK
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -33.33% and -23.72%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is the highest in its industry.
| Div yield(5 year avg) | 0.58% |
|---|---|
| Div growth rate (5 year) | -11.81% |
| Payout ratio (TTM) | 510.70% |
| EPS growth(5 years) | 23.83 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -23.73 |
More ▼
